Multidisciplinary management of patients with post-Covid syndrome
Post-Covid Syndrome Cohort
This study is trying to find better ways to help people with ongoing symptoms after COVID-19 by looking at their health data and blood markers to improve treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 750 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Pierre-Bénite) |
| Trial ID | NCT05805566 on ClinicalTrials.gov |
What this trial studies
This study focuses on patients experiencing persistent symptoms following SARS-CoV2 infection, known as post-Covid syndrome. It aims to create a clinical database to better understand these complex cases and identify blood markers that could predict the disease's progression and inform treatment strategies. The study includes both retrospective and prospective cohorts of patients who have been referred for multidisciplinary care. By analyzing the data collected, the research seeks to enhance the management of post-Covid symptoms and improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 with documented SARS-Cov2 pneumonia and persistent or severe symptoms lasting beyond 4 weeks.
Not a fit: Patients with untreated comorbidities or those who refuse to allow their data to be used for research purposes may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients suffering from debilitating post-Covid symptoms.
How similar studies have performed: Other studies have explored post-Covid syndrome, but this approach of creating a comprehensive clinical database and analyzing blood markers is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: All patients who have joined the Epsilon care pathway since its opening in February 2022, i.e.: * Patients with post-Covid syndrome referred to the Epsilon sector from the city medicine: * Patient with documented SARS-Cov2 pneumonia * With persistent and severe symptoms beyond 4 weeks or complex or disabling symptoms beyond 3 months * Patient over 18 years old. Post-hospital sector: * Patient with documented SARS-Cov2 pneumonia * Hospitalized for oxygen therapy (at least 48h) * Not having a referring pulmonologist * Not institutionalized * With a life expectancy of more than 6 months. Exclusion Criteria: * Patient refusing that this data to be used for research purposes (objection form). * Patient with untreated comorbidities
Where this trial is running
Pierre-Bénite
- Department of Acute Pneumology and Thoracic Oncology, Hôpital Lyon Sud, Hospices Civils de Lyon — Pierre-Bénite, France (Recruiting)
Study contacts
- Principal investigator: Sébastien COURAUD, Pr — Department of Acute Pneumology and Thoracic Oncology, Hôpital Lyon Sud, Hospices Civils de Lyon
- Study coordinator: Sébastien COURAUD, Pr
- Email: Sebastien.couraud@chu-lyon.fr
- Phone: +33 (0)4 78 86 44 01
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.